First Wave BioPharma CEO James Sapirstein to Present at the Planet MicroCap Showcase
First Wave BioPharma, Inc. (FWBI)
Company Research
Source: GlobeNewswire
BOCA RATON, Fla., April 17, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced that James Sapirstein, Chairman and CEO of First Wave BioPharma, will present at the Planet MicroCap Showcase, which will be held April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas. Details of the event are as follows: Event:Planet MicroCap ShowcaseDate: Wednesday, May 1, 2024Time:11:30 am – 12:00 pm PDTLocation:Paris Hotel & Casino, Las VegasRegistration:https://planetmicrocapshowcase.com/signup During the conference, members of the First Wave BioPharma management team will conduct one-on-one meetings with registered investors, showcasing the company’s business and clinical development strategy, recent corporate achievements, and anticipated milestones. About Fir
Show less
Read more
Impact Snapshot
Event Time:
FWBI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FWBI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FWBI alerts
High impacting First Wave BioPharma, Inc. news events
Weekly update
A roundup of the hottest topics
FWBI
News
- First Wave BioPharma Announces Invited Paper for Special Edition on Celiac Disease in Peer-Reviewed Scientific Journal, Nutrients [Yahoo! Finance]Yahoo! Finance
- First Wave BioPharma Announces Invited Paper for Special Edition on Celiac Disease in Peer-Reviewed Scientific Journal, NutrientsGlobeNewswire
- First Wave BioPharma CEO James Sapirstein to Participate in 2024 Longwood Healthcare Leaders ConferenceGlobeNewswire
- Here's Why First Wave BioPharma (FWBI) Is a Great 'Buy the Bottom' Stock Now [Yahoo! Finance]Yahoo! Finance
- First Wave BioPharma (FWBI) Upgraded to Buy: What Does It Mean for the Stock? [Yahoo! Finance]Yahoo! Finance
FWBI
Analyst Actions
- 3/25/24 - HC Wainwright
FWBI
Sec Filings
- 4/3/24 - Form 4
- 4/3/24 - Form 4
- 3/29/24 - Form 10-K
- FWBI's page on the SEC website